Varex Imaging Co. (NASDAQ:VREX) CEO Sells $98,338.76 in Stock

Varex Imaging Co. (NASDAQ:VREX) CEO Sunny Sanyal sold 8,749 shares of the firm’s stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $11.24, for a total transaction of $98,338.76. Following the completion of the sale, the chief executive officer now owns 190,193 shares of the company’s stock, valued at $2,137,769.32. This trade represents a 4.40 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Varex Imaging Trading Down 19.7 %

Shares of VREX opened at $8.28 on Friday. Varex Imaging Co. has a twelve month low of $7.77 and a twelve month high of $18.17. The company has a current ratio of 4.36, a quick ratio of 2.50 and a debt-to-equity ratio of 1.02. The firm has a market capitalization of $341.14 million, a P/E ratio of -7.08 and a beta of 0.65. The firm’s 50-day moving average is $12.80 and its two-hundred day moving average is $13.42.

Varex Imaging (NASDAQ:VREX) last released its quarterly earnings data on Thursday, February 6th. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.03. Varex Imaging had a positive return on equity of 4.00% and a negative net margin of 5.79%. On average, research analysts predict that Varex Imaging Co. will post 0.53 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. StockNews.com raised Varex Imaging from a “hold” rating to a “buy” rating in a report on Friday, February 7th. Oppenheimer decreased their price target on Varex Imaging from $30.00 to $23.00 and set an “outperform” rating on the stock in a research note on Friday, February 7th. Finally, B. Riley reaffirmed a “buy” rating and set a $22.00 price objective (up previously from $21.00) on shares of Varex Imaging in a report on Friday, February 7th.

Institutional Investors Weigh In On Varex Imaging

Several institutional investors and hedge funds have recently made changes to their positions in the business. Nuveen Asset Management LLC increased its holdings in Varex Imaging by 0.5% during the 4th quarter. Nuveen Asset Management LLC now owns 161,344 shares of the company’s stock valued at $2,354,000 after acquiring an additional 791 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Varex Imaging by 4.1% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,072 shares of the company’s stock valued at $322,000 after purchasing an additional 864 shares during the last quarter. Barclays PLC increased its stake in shares of Varex Imaging by 1.1% during the 4th quarter. Barclays PLC now owns 98,964 shares of the company’s stock worth $1,444,000 after purchasing an additional 1,081 shares in the last quarter. Isthmus Partners LLC raised its position in shares of Varex Imaging by 0.8% during the 4th quarter. Isthmus Partners LLC now owns 149,874 shares of the company’s stock worth $2,187,000 after purchasing an additional 1,260 shares during the last quarter. Finally, Quadrant Capital Group LLC lifted its stake in Varex Imaging by 115.4% in the 4th quarter. Quadrant Capital Group LLC now owns 2,837 shares of the company’s stock valued at $41,000 after buying an additional 1,520 shares in the last quarter.

Varex Imaging Company Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.